SCHEMBL9457152

SCHEMBL9457152

CCCCCCCCCCCC(C[C@H]1OC(=O)[C@@H]1CCCCCC)OC(=O)C(CC(C)C)NC(=O)NCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 9/20 0.67
CNR1 P21554 5/20 0.67
DAGLB Q8NCG7 2/20 0.67
MAPT P10636 2/20 0.67
MEN1 O00255 1/20 0.67
NR1I2 O75469 1/20 0.67
ABHD16A O95870 1/20 0.67
LPL P06858 1/20 0.67
LIPC P11150 1/20 0.67
PNLIP P16233 1/20 0.67
ACHE P22303 1/20 0.67
FASN P49327 1/20 0.67
KMT2A Q03164 1/20 0.67
PLA2G7 Q13093 1/20 0.67
ABHD12 Q8N2K0 1/20 0.67
ABHD6 Q9BV23 1/20 0.67
LIPG Q9Y5X9 1/20 0.67
KDM4E B2RXH2 1/20 0.67
USP2 O75604 1/20 0.67
CYP3A4 P08684 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9457160 1.00 DAGLA (0.67) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL9457154 1.00 DAGLA (0.67) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL715188 0.89 DAGLA (0.67) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL13210083 0.89 DAGLA (0.67) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL712215 0.88 DAGLA (0.70) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL23347436 0.84 DAGLA (0.78) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL9457606 0.84 DAGLA (0.78) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL9457613 0.84 DAGLA (0.78) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL9457615 0.84 DAGLA (0.78) DAGLACNR1DAGLBMAPTMEN1
SCHEMBL26373886 0.84 DAGLA (0.78) DAGLACNR1DAGLBMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246960-A Used to treat obesity, hyperlipaemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1993-09-21 US disclosed
US-5175186-A Inhibits pancreas lepase and useful agent in treatment of obesity, hyperlipemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1992-12-29 US disclosed
US-4931463-A PANCREAS LIPASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1990-06-05 US disclosed